Trial Profile

A phase I trial investigating the pharmacokinetics of OX 27 in volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Oct 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sufentanil (Primary)
Indications Cancer pain
Focus Pharmacokinetics

Most Recent Events

25 Oct 2011 New source identified (European Clinical Trials Database record).
14 Jun 2011 Pharmacokinetic outcomes were reported in an Orexo media release.
01 Jun 2011 Status changed from not stated to completed.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com